Frontlight ResearchEarly access
Trial site
Athens Medical Center
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Peripheral artery disease3 trials
- Bladder cancer2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Idiopathic pulmonary fibrosis1 trial
- Kidney cancer1 trial
- Metastatic breast cancer1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Hoffmann-La Roche2 trials
- Daiichi Sankyo1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Horizon Therapeutics Ireland Designated Activity Company1 trial
- and 1 more
Running trials
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Peripheral artery disease1 recruiting
Closed trials
Completed
Terminated
Terminated
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026